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Background: Therapeutic hypothermia (TH) significantly improves outcomes when used in comatose patients (pts) treated for out-of-hospital 
cardiac arrest (OHCA). The presence of myoclonus or seizure activity following OHCA is associated with a very poor prognosis. However, the 
prevalence and prognostic impact of myoclonus or seizure activity in pts resuscitated from OHCA and treated with TH have not been fully described.
Methods: From January 2007 through September 2009, 59 consecutive comatose pts presenting to our coronary care unit after in-hospital 
cardiac arrest (IHCA) or OHCA were treated with TH. Our protocol offered TH to unselected pts resuscitated after IHCA and OHCA, regardless of 
hemodynamics, length of resuscitation, time to return of spontaneous circulation, recent operative status, or presenting cardiac rhythm. Pts with 
IHCA were treated with TH if the event was cardiac in origin. Retrospective, detailed clinical data was obtained on each pt.
Results: The majority of patients treated with TH suffered OHCA (81%) compared to IHCA (19%). Of the 11 pts with IHCA, 91% (10/11) had 
ventricular fibrillation (VF) as their initial rhythm. In the 59 total pts treated with TH, 10 (16.9%) exhibited myoclonus within 24 hours of TH, 5 of 
which had evidence of status epilepticus (SE). Three (5.1%) additional pts had SE on an EEG with no documented myoclonus. In the 13 pts (22.0%) 
with myoclonus or SE, survival to hospital discharge was 0% (0/13), compared to 58.7% (27/46) in pts without myoclonus or SE (p < 0.05). There 
were no significant differences in age (62.9 vs 54.9 years), average time from arrest to initiation of TH (5.9 vs 5.7 hours), or documented VF (71% vs 
53%) in pts with or without myoclonus or SE. Upon rewarming, 46.2% (6/13) of the pts. had continued myoclonus or SE despite treatment with TH 
and antiepileptic drugs.
Conclusions: A significant number of pts develop myoclonus or SE after IHCA or OHCA. Despite treatment with TH, the outcomes in these patients 
are universally poor. It may be reasonable to consider early withdrawal of care when myoclonus or SE are present in pts. being considered for or 
treated with TH.
